EAACI position statement on asthma exacerbations and severe asthma.
about
Clinical usefulness of mepolizumab in severe eosinophilic asthmaThe efficacy and safety of reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: A systematic review and meta-analysis.Impact of rhinitis on asthma severity in school-age children.Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma.A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.Prevalence of IgE-mediated allergy and evaluation of Th1/Th2 cytokine profiles in patients with severe bronchial asthma.Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisons.Severe asthma features in children: a case-control online surveyEconomic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthma.IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?The role of autophagy in allergic inflammation: a new target for severe asthmaGenetic Signatures of Asthma Exacerbation.Advances in the treatment of virus-induced asthma.Tiotropium for the treatment of asthma in adolescents.Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy.A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaHookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma.Age, sex and the association between skin test responses and IgE titres with asthma.Survey of physicians' attitudes toward the use of magnesium sulfate for acute asthma exacerbations in Turkey.Allergy in severe asthma.Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile.IL-25: the missing link between allergy, viral infection, and asthma?Anti-IL5 therapies for asthma.Efficacy and Safety of Tiotropium in Children and Adolescents.Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.Moving toward consensus on diagnosis and management of severe asthma in adults.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.
P2860
Q26746215-AF4364B2-F9F3-4B85-A653-4FC4CF4612E0Q30248905-FB0F5205-8853-41DB-AD46-67CFB3C2682EQ34406505-1C668462-C0F1-45CA-9E0B-187E7F3A3E90Q34511431-481857A2-2716-417B-B927-95C762EE43E2Q35092135-3A2FC488-1018-475D-869B-4A6B72DC36CCQ36048487-0CAB329F-2DB8-43AC-AFB7-B37F3D79F0F5Q36239388-020AB850-D403-4682-922C-F83BA7412E2DQ36489762-38BD2569-D09A-4E97-BC46-C8E23975C85AQ36733079-B6A854AB-55E2-40C1-BB57-55DDDCA063A8Q37125528-D757585D-FE48-41F7-8C3C-B806AF20D72AQ37151423-7D613D64-8258-4F95-82E1-2A06019E9AD0Q37702899-451878A2-A4DE-4448-81EB-AAAA34E40321Q38810784-78304281-610B-4148-BBCA-2A9E114C574BQ39007200-8C4BF2BC-A296-4D88-A57D-6CF38AE966F4Q39192905-87E6B7D6-BBFD-42EF-87F9-B0D4A173B33BQ39218466-C6B2FD0A-B63B-4CC0-8B82-83EF0419741FQ39296277-069A7F86-86F9-4994-8B2E-DF2FE4D766BAQ40108906-6EC7A7F9-928C-42B6-9937-A6DF787DEB87Q40457935-7D8A50E1-C1BC-401C-B05E-64B5A0BC77A7Q40488845-05AFC4EA-45D8-45B3-8710-A2F128C97150Q40948508-AB911174-399A-49F4-B131-7E2DF030C92AQ41719913-92B43466-2726-436E-A6B9-FB6A9ADF62C4Q47551081-49319B0E-B02D-43ED-B814-91521C98C0CEQ47554173-F66E6ED4-36A3-4FAC-8EBD-7F66BCAE52F3Q47643706-93BEBA34-03F9-4BB9-8C6C-2090904217C8Q47719552-FB471D9A-D9F3-42EA-99D3-3FE73E3F36EAQ50106766-E45570FB-B302-4C96-9679-1EA5DA8E9FA7Q53072682-9E13215C-AB84-4D5C-83F8-24A94FE8D009
P2860
EAACI position statement on asthma exacerbations and severe asthma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
EAACI position statement on asthma exacerbations and severe asthma.
@en
type
label
EAACI position statement on asthma exacerbations and severe asthma.
@en
prefLabel
EAACI position statement on asthma exacerbations and severe asthma.
@en
P2093
P50
P356
P1433
P1476
EAACI position statement on asthma exacerbations and severe asthma.
@en
P2093
E Hamelmann
F Martinez
S Sergejeva
P304
P356
10.1111/ALL.12275
P50
P577
2013-11-06T00:00:00Z